UPSIT的子项目可以预测帕金森病的运动进展
Yu-Hsuan Lin1, Ting-Chun Fang1, Hsin-Bei Lei1
1The Department of Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan.
Frontiers in neurology
|November 8, 2023
概括
保存愉快和中性气味的识别可以预测帕金森病 (PD) 的运动进展. 检测特定的气味可以帮助识别患有更快PD进展风险较高的患者.
科学领域:
- 神经学 神经学
- 嗅觉功能障碍研究 嗅觉功能障碍研究
- 帕金森病生物标志物 帕金森病生物标志物
背景情况:
- 帕金森病 (PD) 中的低 (嗅觉减弱) 和运动进展之间的联系仍在争论中.
- 这项研究调查了使用宾夕法尼亚大学气味识别测试 (UPSIT) 识别特定气味是否可以预测PD患者的运动症状进展.
研究的目的:
- 为了确定保存的气味识别能力是否预测帕金森病的运动进展.
- 为了识别与PD快速运动进展风险相关的特定气味.
- 为了评估PD运动进展的气味识别的预测准确性.
主要方法:
- 在两次临床访问中,招募了PD患者,在两次临床访问中持续使用药物.
- 根据UPDRS第3部分和莱沃多巴剂量变化,将患者分为快速,中等和缓慢的运动进展组.
- 分析UPSIT气味识别以计算快速进展的几率比率,并使用ROC曲线分析.
主要成果:
- 分析了117名PD患者.
- 保持与快速运动进展相关的中性/愉快气味 (例如香,桃) 的识别.
- 识别1.5个或更多的风险气味预测了快速进展,敏感度为85.7%,AUC为0.687.
结论:
- 保持中性/愉快气味的识别可以作为PD运动进展的预测指标.
- 使用≥1.5风险气味的门提高了快速运动进展的预测.
- 在患有类似初始运动残疾的PD患者中,更好的愉快/中性气味识别可能表明"身体优先"亚型的进展更快.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.8K
05:38Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
18.0K
相关概念视频
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564
